Actionable news
All posts from Actionable news
Actionable news in PCRX: Pacira Pharmaceuticals, Inc.,

Pacira Pharmaceuticals (PCRX) Marked As A Dead Cat Bounce Stock

Trade-Ideas LLC identified Pacira Pharmaceuticals ( PCRX) as a "dead cat bounce" (down big yesterday but up big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Pacira Pharmaceuticals as such a stock due to the following factors:

  • PCRX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $32.9 million.
  • PCRX has traded 197,887 shares today.
  • PCRX is up 3.1% today.
  • PCRX was down 6% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in PCRX with the Ticky from Trade-Ideas. See the FREE profile for PCRX NOW at Trade-Ideas More details on PCRX: Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, commercializes, and manufactures proprietary pharmaceutical products primarily for use in hospitals and ambulatory surgery centers in the United States. PCRX has a PE ratio of 51. Currently there are 6 analysts that rate Pacira Pharmaceuticals a buy, no analysts rate it a sell, and 1 rates it a hold. The average volume for Pacira Pharmaceuticals has been 833,100 shares per day over the past 30 days. Pacira has a market cap of $1.9 billion and is part of the health care sector and drugs industry. The stock has a beta of 2.33 and a...